ADMA Biologics, Inc.
ADMA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $198 | -$28 | -$66 | -$72 |
| Dep. & Amort. | $8 | $8 | $7 | $5 |
| Deferred Tax | -$84 | $0 | $0 | $0 |
| Stock-Based Comp. | $14 | $6 | $5 | $3 |
| Change in WC | -$19 | -$10 | -$18 | -$52 |
| Other Non-Cash | $2 | $33 | $12 | $2 |
| Operating Cash Flow | $119 | $9 | -$60 | -$112 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$8 | -$5 | -$14 | -$14 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$0 | -$0 | $0 | $0 |
| Investing Cash Flow | -$9 | -$5 | -$14 | -$14 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$60 | -$24 | $52 | -$0 |
| Stock Issued | $7 | $0 | $65 | $121 |
| Stock Repurch. | $0 | -$1 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$6 | -$14 | -$8 | -$0 |
| Financing Cash Flow | -$58 | -$39 | $109 | $121 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $52 | -$35 | $35 | -$5 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $51 | $87 | $51 | $56 |
| End Cash | $103 | $51 | $87 | $51 |
| Free Cash Flow | $110 | $4 | -$73 | -$126 |